{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "La neutrop\u00e9nie f\u00e9brile secondaire \u00e0 une chimioth\u00e9rapie n\u00e9cessite une hospitalisation dans 20 \u00e0 30 % des cas, et est alors associ\u00e9e \u00e0 une mortalit\u00e9 sup\u00e9rieure \u00e0 10 %. Les patients hospitalis\u00e9s pour une neutrop\u00e9nie f\u00e9brile n\u00e9cessitent des mesures d\u2019isolement strictes, avec parfois des r\u00e9percussions non n\u00e9gligeables sur les plans physique et psychique. Les facteurs de croissance granulocytaire (G-CSF) tiennent une place bien \u00e9tablie dans les pr\u00e9ventions primaire et secondaire de la neutrop\u00e9nie li\u00e9e aux cycles de chimioth\u00e9rapie. Cependant, la place des G-CSF dans le traitement curatif de la neutrop\u00e9nie f\u00e9brile postchimioth\u00e9rapie semble moins claire. Cet article a pour but de r\u00e9sumer l\u2019\u00e9vidence et discuter des recommandations actuelles dans cette indication th\u00e9rapeutique."
      ]
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33085256",
  "DateCompleted": {
    "Year": "2020",
    "Month": "10",
    "Day": "26"
  },
  "DateRevised": {
    "Year": "2020",
    "Month": "10",
    "Day": "26"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "fre"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1660-9379",
      "JournalIssue": {
        "Volume": "16",
        "Issue": "711",
        "PubDate": {
          "Year": "2020",
          "Month": "Oct",
          "Day": "21"
        }
      },
      "Title": "Revue medicale suisse",
      "ISOAbbreviation": "Rev Med Suisse"
    },
    "ArticleTitle": "[Granulocyte-Colony Stimulating Factors as adjunctive therapy in patients with neutropenic fever].",
    "Pagination": {
      "StartPage": "1995",
      "EndPage": "2000",
      "MedlinePgn": "1995-2000"
    },
    "Abstract": {
      "AbstractText": [
        "Chemotherapy induced neutropenic fever requires a hospitalization in 20-30 % of cases and is then associated with a mortality above 10 %. Hospitalized patients require strict isolation, which sometimes results in a substantial physical and psychological burden. Granulocyte-colony stimulating factors (G-CSF) are established in the primary and secondary prevention of chemotherapy-induced neutropenia. However, their role as adjunctive therapy in patients with neutropenic fever is less clear. This review resumes current best evidence in this area and discusses current recommendations."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Service de m\u00e9decine interne g\u00e9n\u00e9rale, D\u00e9partement de m\u00e9decine, HUG, 1211 Gen\u00e8ve 14."
          }
        ],
        "LastName": "Buchs",
        "ForeName": "Elisa",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Service d'h\u00e9matologie, D\u00e9partement d'oncologie, HUG et Facult\u00e9 de m\u00e9decine, Universit\u00e9 de Gen\u00e8ve, 1211 Gen\u00e8ve 4."
          }
        ],
        "LastName": "Chalandon",
        "ForeName": "Yves",
        "Initials": "Y"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Service d'oncologie, D\u00e9partement d'oncologie, HUG, 1211 Gen\u00e8ve 14."
          }
        ],
        "LastName": "Friedlaender",
        "ForeName": "Alex",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Service de m\u00e9decine interne g\u00e9n\u00e9rale, D\u00e9partement de m\u00e9decine, HUG, 1211 Gen\u00e8ve 14."
          }
        ],
        "LastName": "Stirnemann",
        "ForeName": "J\u00e9r\u00f4me",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Service de m\u00e9decine interne g\u00e9n\u00e9rale, D\u00e9partement de m\u00e9decine, HUG, 1211 Gen\u00e8ve 14."
          }
        ],
        "LastName": "Agoritsas",
        "ForeName": "Thomas",
        "Initials": "T"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ],
    "VernacularTitle": "Facteurs de croissance granulocytaire dans le traitement curatif des neutrop\u00e9nies f\u00e9briles."
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Rev Med Suisse",
    "NlmUniqueID": "101219148",
    "ISSNLinking": "1660-9379"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "143011-72-7",
      "NameOfSubstance": "Granulocyte Colony-Stimulating Factor"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Combined Modality Therapy"
    },
    {
      "QualifierName": [
        "drug therapy",
        "prevention & control"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Granulocyte Colony-Stimulating Factor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy",
        "prevention & control"
      ],
      "DescriptorName": "Neutropenia"
    }
  ],
  "CoiStatement": "Les auteurs n\u2019ont d\u00e9clar\u00e9 aucun conflit d\u2019int\u00e9r\u00eats en relation avec cet article."
}